Palvella Therapeutics Inc.

NASDAQ: PVLA
Share price (1/8/25): $14.25
Market cap (1/8/25): $18.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Initial registration of new securities

Business combination disclosure

Business combination disclosure

Prospectus supplement

Business combination disclosure

Ownership Filter

Frazier Life Sciences Public Fund, L.P.

Samsara BioCapital, L.P.

Suvretta Capital Management, LLC

News Filter

Announces Closing of Merger With Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million

Material Modification to Rights of Security Holders, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Other Events, Financial Statements or Exhibits

Shareholder Vote Results, Other Events, Financial Statements or Exhibits

FDA Orphan Products Grants Are Based on Scientific and Technical Merit as Determined by Rare Disease and Regulatory Experts

Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

SEC STAFF LETTER

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Correspondence with the SEC